TRIADERM CRM 0.025% DIN 00716952
Status: Cancelled Post Market
Holder: TARO PHARMACEUTICALS INC
Molecule: TRIAMCINOLONE ACETONIDE .025 %
Health Canada record
| Active ingredient(s) | TRIAMCINOLONE ACETONIDE .025 % |
|---|---|
| Dosage form | Cream |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D07AB09 TRIAMCINOLONE |
| Original market date | 31-Dec-1979 |
| Current status date | 04-Feb-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TRIAMCINOLONE ACETONIDE .025 %
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02194074 | ARISTOCORT D - CRM TOP 0.025% | GLADES, DIVISION OF STIEFEL CANADA INC. | Cream | TRIAMCINOLONE ACETONIDE .025 % | Cancelled Post Market |